Cambridge Cognition Holdings Plc (AIM: COG)

Market Cap	17.49M
Revenue (ttm)	13.08M
Net Income (ttm)	-1.32M
Shares Out	41.64M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	57,016
Average Volume	66,881
Open	42.53
Previous Close	42.00
Day's Range	41.75 - 43.00
52-Week Range	26.40 - 60.00
Beta	0.76
RSI	92.13
Earnings Date	May 2, 2025

About AIM: COG

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides ...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 119
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: COG

Financial Performance

In 2023, COG's revenue was 13.52 million, an increase of 7.15% compared to the previous year's 12.61 million. Losses were -3.51 million, 757.7% more than in 2022.